Melissa Doak, NP
Family Nurse Practitioner in New York, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 210,832 in Family Nurse Practitioner, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Melissa Doak, NP reported a CMS MIPS final score of 95.2/100 - above the 83.5 national average - and filed 1,498 Medicare Part D claims in 2023.
- 95.2/100
- MIPS score · +12 vs avg
- 1K
- Part D claims, 2023
- 87%
- generic prescribing
- ≥78th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Melissa Doak, NP
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1801382759), first enumerated 07/03/2018.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,498 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 95.2/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Melissa Doak, NP's individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1801382759 · Family Nurse Practitioner
NPI-10 · ENUM-RECENT · TAX-MEGA · MIPS-ELITE · RX-MID · BOOK-MID · PHOTO-FINISH
- NPI-10 1801382759
- ENUM-RECENT 2018
- TAX-MEGA 211K Family Nurse
- MIPS-ELITE 95.2/100
- RX-MID 1,498
- BOOK-MID 12,508 in New York
- PHOTO-FINISH Carol Henderson · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Doak · this prov…
Doak · this provider
95.2 MIPS pts
- Carol Henderson …
Carol Henderson
95.2 MIPS pts
- Jillian Kelly · …
Jillian Kelly
95.2 MIPS pts
- Lydia Staiger · …
Lydia Staiger
95.2 MIPS pts
- Ashlin Thuman · …
Ashlin Thuman
95.2 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Melissa Doak, NP's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
95 ≥ 78th percentile 78% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Melissa Doak, NP sits
This provider among family nurse practitioner peers
Across the 26,556 family nurse practitioner providers who report both Medicare Part D prescribing and a MIPS quality score, Melissa Doak, NP writes more Part D claims than 76% of them and scores higher on MIPS quality than 79% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one family nurse practitioner peer from a representative sample of 60; the gold marker is Melissa Doak, NP. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Melissa Doak, NP?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Family Nurse Practitioner compares to other specialties among New York providers
Family Nurse Practitioner ranks #14 among New York's specialties (2.3% of in-state providers)
Each bar is a specialty's share of the New York provider total, by primary NUCC taxonomy. The highlighted bar is Family Nurse Practitioner; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Melissa Doak, NP's 2023 MIPS final score plotted against the Family Nurse Practitioner national average
- MIPS Final Score
- 95.2/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Specialty volume Family Nurse Practitioner US NPIs
95.2/100 MIPS final score - 11.7 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Family Nurse Practitioner. Quality dim: 84.7.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1801382759 |
|---|---|
| Specialty | Family Nurse Practitioner |
| Credentials | NP |
| Gender | Female |
| NPI Issued | 07/03/2018 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Melissa Doak, NP's current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1801382759 is the unique 10-digit identifier CMS uses to link Doak across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Alternative Payment Model
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Melissa Doak, NP. To verify Melissa Doak, NP's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
12% brand-name claims vs 87% generic, on 1,498 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,080
- Total Day Supply
- 89,737
- Brand vs Generic
- 12% brand / 87% generic
- Brand Drug Cost
- $100K
- Generic Drug Cost
- $36K
- Opioid Claims
- 67 (4.5% rate)
- Antibiotic Claims
- 35
Patient Demographics
- Average Patient Age
- 72.0 years
- Avg HCC Risk Score
- 0.89
- Gender Split
- 92% female / 8% male
- Age Distribution
- <65: 20, 65-74: 152, 75-84: 73, 85+: 19
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Melissa Doak, NP prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
119 claims
- Omeprazole
Omeprazole
67 claims
- Atorvastatin Calcium
Atorvastatin Calcium
66 claims
- Gabapentin
Gabapentin
48 claims
- Lisinopril 37
Lisinopril
37 claims
- Amlodipine Besylate 36
Amlodipine Besylate
36 claims
- Escitalopram Oxalate 34
Escitalopram Oxalate
34 claims
- Trazodone Hcl 30
Trazodone Hcl
30 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 119 |
| Omeprazole | 67 |
| Atorvastatin Calcium | 66 |
| Gabapentin | 48 |
| Lisinopril | 37 |
| Amlodipine Besylate | 36 |
| Escitalopram Oxalate | 34 |
| Trazodone Hcl | 30 |
| Alendronate Sodium | 29 |
| Hydrochlorothiazide | 29 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Family Nurse Practitioner Overview
How Melissa Doak, NP fits within the Family Nurse Practitioner landscape nationally.
Melissa Doak, NP's 1,498 claims are above the specialty average of 1,222.
Nationwide Family Nurse Practitioner peers with similar MIPS or enrollment year
Two federal-record peer sets for Doak, both outside New York so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (95.2 here).
Same NPPES enumeration year (2018)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Family Nurse Practitioner Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Doak.
One of 12,508 Family Nurse Practitioner providers enrolled in New York, 5 are shown here.
Compare Family Nurse Practitioner nationally: see state-by-state distribution →
Frequently Asked Questions
What is Melissa Doak, NP's specialty? ▼
How much does Melissa Doak, NP prescribe under Medicare Part D? ▼
What is Melissa Doak, NP's Medicare quality score? ▼
Where is Melissa Doak, NP located? ▼
What is Melissa Doak, NP's NPI number? ▼
Does Melissa Doak, NP prescribe more brand-name or generic drugs? ▼
Does Melissa Doak, NP prescribe opioids? ▼
How many Family Nurse Practitioner providers are there in the US? ▼
What drugs does Melissa Doak, NP prescribe most often? ▼
Does Melissa Doak, NP accept Medicare? ▼
How can I verify Melissa Doak, NP's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.